TSSC3 as a potential biomarker in osteosarcoma: implications for angiogenesis
Folia Histochem Cytobiol. · 2026
DOI: 10.5603/fhc.112768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Histochem Cytobiol., 2026. Verfasst von Hanzhen Feng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, 920th Hospital of the Joint Logistics Support Force of PLA, Kunming, China. Hauptthemen laut MEDLINE: Osteosarcoma, Neovascularization, Pathologic, Biomarkers, Tumor, Bone Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, 920th Hospital of the Joint Logistics Support Force of PLA, Kunming, China.
- Department of Pathology, Tengzhou Central People's Hospital, Tengzhou, China.
- Department of Gastroenterology, 920th Hospital of the Joint Logistics Support Force of PLA, Kunming, China.
- Department of Oncology, 920th Hospital of the Joint Logistics Support Force of PLA, Kunming, China.
- Department of Pathology, 920th Hospital of the Joint Logistics Support Force of PLA, Kunming, China. zirannn_gaooo@163.com.
ORCID-Profile: Hanzhen Feng, Wenmang Xu, Qiang Feng, Xiaolong Wei, Meijin Huang, Ziran Gao
Zitieren
APA
Feng, H., Xu, W., Feng, Q., Wei, X., Huang, M., & Gao, Z. (2026). TSSC3 as a potential biomarker in osteosarcoma: implications for angiogenesis. Folia Histochem Cytobiol.. https://doi.org/10.5603/fhc.112768
Vancouver
Feng H, Xu W, Feng Q, Wei X, Huang M, Gao Z. TSSC3 as a potential biomarker in osteosarcoma: implications for angiogenesis. Folia Histochem Cytobiol.. 2026. doi:10.5603/fhc.112768
BibTeX
@article{Feng2026,
author = {Feng, Hanzhen and Xu, Wenmang and Feng, Qiang and Wei, Xiaolong and Huang, Meijin and Gao, Ziran},
title = {TSSC3 as a potential biomarker in osteosarcoma: implications for angiogenesis},
journal = {Folia Histochem Cytobiol.},
year = {2026},
doi = {10.5603/fhc.112768}
}
EUVIMED